Franklin Resources’s Palvella Therapeutics PVLA Stock Holding History

Franklin Resources’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$739K	Buy	4,838 +181	+4%	+$22K	﹤0.01%	2410
2026 Q1	$580K	Buy	4,657 +7	+0.2%	+$730	﹤0.01%	2410
2025 Q4	$487K	Hold	4,650	–	–	﹤0.01%	2416
2025 Q3	$292K	Buy	+4,650	New	+$207K	﹤0.01%	2680
2023 Q1	–	Sell	-377	Closed	-$31.4K	–	2406
2022 Q4	$31.4K	Hold	377	–	–	﹤0.01%	2250
2022 Q3	$35K	Buy	377 +4	+1%	+$516	﹤0.01%	2227
2022 Q2	$56K	Sell	373 -181	-33%	-$33K	﹤0.01%	2230
2022 Q1	$134K	Hold	554	–	–	﹤0.01%	2243
2021 Q4	$167K	Buy	+554	New	+$177K	﹤0.01%	2271

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Franklin Resources's PVLA Position: Q2 2026 in Review

Franklin Resources increased its Palvella Therapeutics (PVLA) stake by 3.9% in Q2 2026, buying an estimated $22K and bringing the position to 4,838 shares worth $739K. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

Franklin Resources first reported a position in PVLA in Q4 2021 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Franklin Resources held 4,838 shares of Palvella Therapeutics worth $739K as of Q2 2026.
Franklin Resources bought 181 Palvella Therapeutics shares in Q2 2026, an estimated $22K.
Palvella Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2410 holding.
Franklin Resources first reported a position in Palvella Therapeutics in Q4 2021 and has held it in 9 quarters since.
197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.